Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 2—February 2009
Research

Prospective Surveillance of Invasive Group A Streptococcal Disease, Fiji, 2005–2007

Andrew C. SteerComments to Author , Adam Jenney, Joseph Kado, Michael F. Good, Michael Batzloff, Lepani Waqatakirewa, E. Kim Mullholland, and Jonathan R. Carapetis
Author affiliations: University of Melbourne, Melbourne, Victoria, Australia (A.C. Steer, A. Jenney, E.K. Mullholland, J.R. Carapetis); Ministry of Health, Suva, Fiji (J. Kado, L. Waqatakirewa); Queensland Institute of Medical Research, Brisbane, Queensland, Australia (M.F. Good, M. Batzloff); London School of Hygiene and Tropical Medicine, London, UK (E.K. Mullholand); Menzies School of Health Research, Casuarina, Northern Territory, Australia (J.R. Carapetis)

Main Article

Table 3

Underlying coexisting medical conditions in patients with invasive GAS disease, Fiji, 2005–2007

Condition No. (%) patients
Diabetes 25 (42)
Renal disease 13 (22)
Cardiac disease 13 (22)
Malignancy 5 (8)
Immunosuppression 2 (3)
Lung disease 3 (5)
Liver disease
 1 (2)
Any coexisting condition 38 (63)
Only 1 coexisting condition 21 (35)
2 coexisting conditions† 11 (18)
>2 coexisting condition† 6 (10)

*GAS, group A streptococci.
†Nine patients had diabetes and renal disease.

Main Article

Page created: December 08, 2010
Page updated: December 08, 2010
Page reviewed: December 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external